NCT05204901

Brief Summary

This is a trial on the feasibility of magnetic tracking for the confirmation of nasogastric tube location in human patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 4, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2022

Completed
Last Updated

April 25, 2023

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

December 5, 2021

Last Update Submit

April 23, 2023

Conditions

Keywords

nasogastric tubechest X-rayconfirmation of placementmagnetic tracking

Outcome Measures

Primary Outcomes (2)

  • Probability of visualising a leftward deviation of the magnetic tipped guide-wire inferior to the xiphisternum

    The investigators will measure the rate of visualisation of a left-ward deviation of the magnet below the plane of xiphisternum in participants whose nasogastric tube deviates in such a way on chest X-ray.

    6 months

  • Difference in the distance between the magnet and the datum with that between the nasogastric tube on chest X-ray and the datum

    The investigators will compare difference in distance (measured in millimetres) between the path of the nasogastric tube seen on magnetic tracking with that seen on chest X-ray by comparing them against a vertical midline (datum) centred over the midpoint of the sternum.

    6 months

Secondary Outcomes (2)

  • test-retest variability

    6 months

  • Adverse events related to the device

    6 months

Study Arms (1)

Magnetic tracking

EXPERIMENTAL

This is the only arm of the study. All 12 participants will undergo the insertion of the magnetic-tipped guidewire into their nasogastric tube after its correct placement is confirmed by chest X-ray.

Device: Insertion and withdrawal of a magnetic-tipped wire into the lumen of the nasogastric tube for tracking of its position

Interventions

In each participant, the investigator will place sensors on two sites of the sternum and track the location of the magnet as it is inserted and withdrawn from the nasogastric tube in the patients.

Magnetic tracking

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients from the general ward or the Otorhinolaryngology clinic of Tan Tock Seng Hospital who had an NGT inserted within the last 10 days and chest X-ray confirming its correct placement
  • The NGT inserted is a Ryles tube size Fr 14 or 16
  • COVID negative or not deemed to be infective as judged by the prevailing policies at the time of recruitment
  • Age \> or = 21 years
  • BMI \< 35
  • Height \< 1.9m
  • Mentally competent for informed consent

You may not qualify if:

  • Radiological:
  • On chest X-ray, the length of the NGT distal to the gastroesophageal junction is less than 12cm, or the side-holes of the NGT can be visualized in the esophagus.
  • The NGT is kinked within 10cm of its tip
  • The chest X-ray is rotated such that the thorax is not oriented in the frontal plane
  • The NGT cannot be visualized in the mediastinum
  • The second intercostal space cannot be visualized on chest X-ray
  • Medically unstable:
  • Heart rate \>=100 or \<60
  • Systolic blood pressure \>=160 or \<100
  • SpO2 \<92% in patients with chronic lung disease and \<95% in patients without chronic lung disease
  • Temperature \>= 38 degrees Celsius
  • Chest wall deformity:
  • Patients with pectus carinatum or excavatum, defined by physical examination
  • Patients with the following implants
  • Pacemaker
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tan Tock Seng Hospital

Singapore, 308433, Singapore

Location

Related Publications (2)

  • Miyasaka M, Li H, Tay KV, Phee SJ. A Low-Cost, Point-of-Care Test for Confirmation of Nasogastric Tube Placement via Magnetic Field Tracking. Sensors (Basel). 2021 Jun 30;21(13):4491. doi: 10.3390/s21134491.

  • Li H, Tay KV, Liu J, Ong CYG, Khoo HW, Zhou A, Miyasaka M, Phee SJ. Feasibility of a low-cost magnet tracking device in confirming nasogastric tube placement at point of care, a clinical trial. Sci Rep. 2024 Mar 25;14(1):7068. doi: 10.1038/s41598-024-57455-7.

MeSH Terms

Conditions

Gastrointestinal DiseasesEsophageal Diseases

Interventions

Mutagenesis, Insertional

Condition Hierarchy (Ancestors)

Digestive System Diseases

Intervention Hierarchy (Ancestors)

Protein EngineeringGenetic EngineeringGenetic TechniquesInvestigative TechniquesMutationGenetic VariationGenetic PhenomenaMutagenesis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2021

First Posted

January 24, 2022

Study Start

May 4, 2022

Primary Completion

December 7, 2022

Study Completion

December 7, 2022

Last Updated

April 25, 2023

Record last verified: 2023-04

Locations